Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Pro-Dex stock | $42.6

Own Pro-Dex stock in just a few minutes.

Fact checked

Pro-Dex, Inc is a medical instruments & supplies business based in the US. Pro-Dex shares (PDEX) are listed on the NASDAQ and all prices are listed in US Dollars. Pro-Dex employs 117 staff and has a trailing 12-month revenue of around USD$36.2 million.

How to buy shares in Pro-Dex

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Pro-Dex. Find the stock by name or ticker symbol: PDEX. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Pro-Dex reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$42.6, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Pro-Dex, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Pro-Dex. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Pro-Dex share price

Use our graph to track the performance of PDEX stocks over time.

Pro-Dex shares at a glance

Information last updated 2020-12-31.
Latest market closeUSD$42.6
52-week rangeUSD$12.83 - USD$42.6
50-day moving average USD$38.3085
200-day moving average USD$28.3078
Wall St. target priceUSD$40
PE ratio 19.942
Dividend yield N/A (0%)
Earnings per share (TTM) USD$1.553

Buy Pro-Dex shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Sofi Invest
$0
Stocks, ETFs, Cryptocurrency
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Moomoo
$0 for US stocks
Stocks, Options, ETFs
$0
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Pro-Dex stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Pro-Dex price performance over time

Historical closes compared with the close of $42.6 from 2020-12-18

1 week (2021-01-07) 48.33%
1 month (2020-12-17) 5.11%
3 months (2020-10-16) 57.60%
6 months (2020-07-16) 124.80%
1 year (2020-01-16) 146.24%
2 years (2019-01-16) 248.61%
3 years (2018-01-16) 500.00%
5 years (2016-01-15) 1,784.96%

Is Pro-Dex under- or over-valued?

Valuing Pro-Dex stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Pro-Dex's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Pro-Dex's P/E ratio

Pro-Dex's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 20x. In other words, Pro-Dex shares trade at around 20x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

Pro-Dex's EBITDA

Pro-Dex's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$7.7 million.

The EBITDA is a measure of a Pro-Dex's overall financial performance and is widely used to measure a its profitability.

Pro-Dex financials

Revenue TTM USD$36.2 million
Operating margin TTM 19.67%
Gross profit TTM USD$13.1 million
Return on assets TTM 15.14%
Return on equity TTM 33.46%
Profit margin 17.34%
Book value $5.197
Market capitalisation USD$119.5 million

TTM: trailing 12 months

Shorting Pro-Dex shares

There are currently 20,054 Pro-Dex shares held short by investors – that's known as Pro-Dex's "short interest". This figure is 1% down from 20,261 last month.

There are a few different ways that this level of interest in shorting Pro-Dex shares can be evaluated.

Pro-Dex's "short interest ratio" (SIR)

Pro-Dex's "short interest ratio" (SIR) is the quantity of Pro-Dex shares currently shorted divided by the average quantity of Pro-Dex shares traded daily (recently around 30852.307692308). Pro-Dex's SIR currently stands at 0.65. In other words for every 100,000 Pro-Dex shares traded daily on the market, roughly 650 shares are currently held short.

However Pro-Dex's short interest can also be evaluated against the total number of Pro-Dex shares, or, against the total number of tradable Pro-Dex shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Pro-Dex's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Pro-Dex shares in existence, roughly 10 shares are currently held short) or 0.0086% of the tradable shares (for every 100,000 tradable Pro-Dex shares, roughly 9 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Pro-Dex.

Find out more about how you can short Pro-Dex stock.

Pro-Dex share dividends

We're not expecting Pro-Dex to pay a dividend over the next 12 months.

Have Pro-Dex's shares ever split?

Pro-Dex's shares were split on a 1:3 basis on 18 June 2010. So if you had owned 3 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Pro-Dex shares – just the quantity. However, indirectly, the new 200% higher share price could have impacted the market appetite for Pro-Dex shares which in turn could have impacted Pro-Dex's share price.

Pro-Dex share price volatility

Over the last 12 months, Pro-Dex's shares have ranged in value from as little as $12.83 up to $42.6. A popular way to gauge a stock's volatility is its "beta".

PDEX.US volatility(beta: 1.33)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Pro-Dex's is 1.3255. This would suggest that Pro-Dex's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Pro-Dex overview

Pro-Dex, Inc. designs, develops, and manufactures powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and maxocranial facial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company was founded in 1978 and is headquartered in Irvine, California.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site